GJC1 Antikörper (N-Term)

Produktnummer ABIN5534076

Produktdetails anti-GJC1 Antikörper

Target: GJC1 (Gap Junction Protein, gamma 1, 45kDa (GJC1))

Bindungsspezifität: AA 89-120, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GJC1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Immunogen: This GJA7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 89-120 amino acids from the N-terminal region of human GJA7.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:50~100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.46 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu GJC1

Target: GJC1 (Gap Junction Protein, gamma 1, 45kDa (GJC1))

Andere Bezeichnung: GJA7 (GJC1 Produkte)

Synonyme: CX45 antikoerper, GJA7 antikoerper, cx45 antikoerper, gja7 antikoerper, MGC52735 antikoerper, GJD3 antikoerper, GJC1 antikoerper, C130009G16Rik antikoerper, Cnx45 antikoerper, Cx45 antikoerper, Gja-7 antikoerper, Gja7 antikoerper, gap junction protein gamma 1 antikoerper, gap junction protein gamma 1 L homeolog antikoerper, gap junction protein, delta 3, 31.9kDa antikoerper, gap junction protein, gamma 1 antikoerper, Gap junction gamma-1 protein antikoerper, GJC1 antikoerper, gjc1.L antikoerper, GJD3 antikoerper, Gjc1 antikoerper, gjc1 antikoerper

Hintergrund: Gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell closely packed transmembrane channels. Proteins, called connexins, purified from fractions of enriched gap junctions from different tissues differ. Connexins are designated by their molecular mass. Another system of nomenclature divides gap junction proteins into 2 categories, alpha and beta, according to sequence similarities at the nucleotide and amino acid levels. For example, CX43 is designated alpha-1 gap junction protein, whereas CX32 and CX26 are called beta-1 and beta-2 gap junction proteins, respectively. This nomenclature emphasizes that CX32 and CX26 are more homologous to each other than either of them is to CX43. Connexins have four transmembrane, three intracellular, and two extracellular regions. Different tissues express different connexins, though tissue specificities overlap, and a given tissue or cell can express several different connexins. Developmental regulation of at least some of the connexin genes has been found. Embryo implantation is regulated in part by temporally changing patterns of expression of connexins in the embryo and the maternal decidua.

Molekulargewicht: 45 kDa

Gen-ID: 10052

UniProt: P36383

Pathways: Cell-Cell Junction Organization